Application of jawbone tissue-derived osteoblast in preparation of pre-vascularization bone cell membrane patch
The construction of prevascularized osteoblast diaphragms through magnetic nanoparticle labeling and layer-by-layer magnetic attraction methods has solved the trauma and infection risks of autologous bone grafting in jaw defect repair, and achieved efficient bone formation and angiogenesis of bone tissue regeneration, providing new theoretical guidance.
Patent Information
- Application Number
- CN202510375326.0
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2025-03-27
- Publication Date
- 2025-08-12
AI Technical Summary
In the prior art, the repair of jaw defects has great trauma in autologous bone graft and high risk of infection after bone graft. The preparation time of cell membranes is long and the cell distribution cannot be accurately controlled, and the complex environment of biological tissue cannot be simulated, resulting in limitations in bone tissue regeneration.
Osteoblasts and vascular endothelial cells were labeled with magnetic nanoparticles. Pre-vascularized osteoblast diaphragms were constructed by layer by layer magnetic attraction, and seed cells were preserved using frozen storage technology to avoid the impact of individual aging.
The construction of pre-vascularized osteoblast diaphragms in vitro was achieved, significantly increasing the expression of VEGF-A and BMP2 proteins, promoting angiogenesis and bone formation, providing new theoretical guidance for bone tissue regeneration engineering, and reducing operating trauma and cost.
Smart Images

Figure CN120464564A_ABST
Abstract
Description
Technical Field
[0001] The present application relates to the field of biomedical technology, and in particular to the use of osteoblasts derived from jaw bone tissue in the preparation of pre-vascularized osteoblast membranes. Background Art
[0002] As the supporting hard tissue of the face, the mandible not only maintains the appearance but also undertakes the important functions of chewing, swallowing, breathing and speaking. Mandibular defects often have a great impact on the patient's physical and mental health and quality of life. Bone defects caused by maxillofacial malignant tumor resection, trauma, infection and other reasons, as well as the loss of alveolar bone height and width caused by site absorption after tooth extraction, have always been difficult problems in mandibular reconstruction and implant restoration. Common treatment methods include autologous bone transplantation, allogeneic bone transplantation, xenogeneic bone transplantation and tissue engineering bone construct transplantation. Autologous bone transplantation eliminates the possible risk of disease infection and antigenicity problems, and also ensures a shorter period of bone integration. However, autologous bone transplantation often faces problems such as too rapid absorption, too high absorption rate, and the risk of hematoma and nerve damage at the bone harvesting site when opening a second surgical area (common bone harvesting sites are ilium, clavicle, skull, mandible, etc.). Intraoral bone harvesting, such as from the mandibular oblique line and chin, offers advantages in ease of operation and minimal trauma. It can often be used to harvest bone for backup during impacted tooth extraction and benign mandibular tumor resection, eliminating the need for additional surgery. However, intraoral bone harvesting not only reduces the amount of bone harvested, but also involves a non-strictly sterile environment, which can easily lead to secondary infection after bone grafting. Furthermore, the long-term viability of autologous frozen mandibular bone and its specific application methods urgently need to be addressed.
[0003] Since researchers first cultivated osteoblastic cells from bone blocks that had been cryopreserved for a long time, numerous studies have explored various methods to improve the post-cryopreservation activity of hip bone or cartilage, including cryopreservation procedures, cryopreservation fluid composition, and sample processing. However, there is limited research on the long-term cryopreservation of active mandibular bone and the evaluation and specific applications of the cells within it. Cell sheet technology has been a popular tissue engineering technique in recent years. Using autologous cells to construct cell sheets has been successfully applied in various tissue engineering projects, and its application in bone defect repair has been particularly rapid.
[0004] The preparation of cell membranes is mainly affected by seed cells and membrane preparation technology. At present, the source of cell membrane seed cells is often from adipose stem cells, bone marrow mesenchymal stem cells and periodontal ligament stem cells. Extracting cells is a trauma in itself, and their transportation and long-term storage are expensive, and they are also affected by the impact of individual aging on seed cells. Common preparation methods for cell membranes include temperature control, pH control, mechanical scraping, etc., but they have a long membrane formation time, cannot accurately control the distribution of cells, are rarely used to construct multi-layer cell membranes, and cannot simulate the complex environment of biological tissues (including vascularization). Therefore, their application in bone tissue regeneration has great limitations. Summary of the Invention
[0005] In response to the deficiencies of the prior art, the present application provides the use of osteoblasts derived from jaw bone tissue in the preparation of pre-vascularized osteoblast membranes.
[0006] In one aspect, the present application provides a method for preparing a pre-vascularized osteoblast membrane, the preparation method comprising the following steps:
[0007] Step S1, freezing fresh jaw tissue;
[0008] Step S2, resuscitating and culturing the frozen jaw tissue to obtain human osteoblasts (HOBs);
[0009] Step S3, labeling the obtained osteoblasts (HOBs) and human umbilical vein endothelial cells (HUVECs) with magnetic nanoparticles;
[0010] Step S4: After labeling, the labeled osteoblasts and human umbilical vein endothelial cells (HUVECs) are magnetically attracted layer by layer to prepare a pre-vascularized osteoblast membrane sheet.
[0011] By adopting the above-mentioned technical scheme, the present application can successfully construct a pre-vascularized osteoblast membrane in vitro by magnetically attracting frozen bone-derived osteoblasts and vascular endothelial cells layer by layer after labeling with magnetic nanoparticles. Compared with the control group, the expression levels of VEGF-A and BMP2 proteins in the pre-vascularized treatment group were significantly increased, indicating that the pre-vascularized osteoblast membrane has a good ability to promote angiogenesis and bone formation, providing new theoretical guidance for optimizing the construction of pre-vascularized bone tissue.
[0012] In certain embodiments, the freezing step is to place the fresh jaw tissue in a cryopreservation protective solution and perform gradient cooling to -80°C for long-term freezing. The cryopreservation protective solution is a culture medium containing 8-12% DMSO, 20-40% FBS, and 50-70% DMEM.
[0013] In certain embodiments, the resuscitation step is performed in a 35°C-37°C water bath.
[0014] In certain embodiments, the magnetic nanoparticles in step S3 are Fe3O4MNPs, and the concentration of the Fe3O4MNPs is 45-55 μg / mL.
[0015] In certain embodiments, step S4 specifically comprises continuously attracting labeled osteoblasts (HOBs) with a super magnet to obtain a single-layer HOBs membrane, inoculating labeled human umbilical vein endothelial cells (HUVECs) on the single-layer HOBs membrane, and then inoculating another layer of osteoblasts (HOBs) on the human umbilical vein endothelial cells (HUVECs) after an interval of 3-4 hours to obtain a pre-vascularized osteoblast membrane.
[0016] On the other hand, the present application also provides a pre-vascularized osteoblast membrane sheet prepared by the preparation method.
[0017] On the other hand, the present application also provides the use of the pre-vascularized osteoblast membrane in bone tissue regeneration engineering.
[0018] On the other hand, the present application also provides the use of osteoblasts derived from jaw tissue in preparing a pre-vascularized osteoblast membrane, wherein the osteoblasts are obtained from fresh jaw tissue by cryopreservation and subsequent thawing and culturing.
[0019] In certain embodiments, the use according to claim 1 is characterized in that the cryopreservation is to place the fresh jaw tissue in a cryopreservation protective solution and perform gradient cooling to -80°C for long-term freezing, wherein the cryopreservation protective solution is a culture medium containing 8-12% DMSO, 20-40% FBS, and 50-70% DMEM.
[0020] Compared with the prior art, this application has the following technical effects.
[0021] 1) This application uses the bone blocks that should have been discarded during the surgery for impacted wisdom teeth in young patients to be minimally invasively removed by ultrasonic osteotome and then cryopreserved. The osteoblasts are then revived and extracted for bone tissue engineering many years later. This solution ensures that the seed cells are not affected by individual aging, and effectively verifies a new source of bone tissue engineering seed cells (frozen bone-derived osteoblasts) and its minimally invasive, easy-to-use and economical long-term storage method.
[0022] 2) This application also actively explored the clinical transformation possibilities of the mandibular tissue sample library. By labeling with magnetic nanoparticles and then magnetically attracting frozen bone-derived osteoblasts and vascular endothelial cells layer by layer, a pre-vascularized osteoblast membrane sheet can be successfully constructed in vitro. Compared with the control group, the expression levels of VEGF-A and BMP2 proteins in the pre-vascularized treatment group were significantly increased, indicating that the pre-vascularized osteoblast membrane sheet has a good ability to promote angiogenesis and bone formation, providing new theoretical guidance for the optimization of the construction of pre-vascularized bone tissue, and providing a new method for the clinical transformation of frozen bone sample libraries and the repair and regeneration of bone tissue defects. BRIEF DESCRIPTION OF THE DRAWINGS
[0023] Figure 1 This is the bone harvesting process during impacted wisdom tooth extraction.
[0024] Figure 2 This is a microscopic morphology of the bone tissue sample surface, where the black arrow indicates the bone pit.
[0025] Figure 3 To investigate the morphological changes of osteoblasts cultured and expanded by adherent culture after bone tissue was revived for different periods of time.
[0026] Figure 4 To compare the immunofluorescence staining of osteoblasts derived from bone tissues cryopreserved for different time periods.
[0027] Figure 5 To compare the proliferation ability of osteoblasts derived from bone tissues cryopreserved for different time periods.
[0028] Figure 6 To compare ALP staining of osteoblasts derived from bone tissues frozen for different time periods.
[0029] Figure 7 Comparison of cells after osteogenic induction by Alizarin red staining.
[0030] Figure 8 To compare the calcium nodule mineralization of cryopreserved bone-derived osteoblasts in vitro using ARS staining and calcium nodule counting.
[0031] Figure 9 Comparison of SA-β-gal (senescence-related marker) staining of cryopreserved bone-derived osteoblasts. A shows SA-β-gal-positive cells (200×) (indicated by white arrows), and B shows the comparison of SA-β-gal staining positivity rates in each group.
[0032] Figure 10 To compare the apoptosis rate of osteoblasts derived from cryopreserved bones.
[0033] Figure 11 G-banded chromosome karyotype analysis of osteoblasts derived from bone blocks at different cryopreservation times.
[0034] Figure 12 Osteoblasts derived from bone tissue that had been frozen for 6 months were stained with ALP and Alizarin red after 0, 4, 7, and 14 days of osteogenic induction.
[0035] Figure 13 Live / dead cell double staining results showed that there was no difference in the survival of HOBs and HUVECs labeled with 50 μg / mL Fe3O4 MNPs compared with the cell control group.
[0036] Figure 14 HOBs and HUVECs were incubated with 5, 25, and 50 μg / mL Fe3O4 MNPs for 1 h, and cellular endocytosis was detected by Prussian blue staining (×100).
[0037] Figure 15 The effect of different labeling time of Fe3O4 MNPs on the adhesion and film formation (DAPI+phalloidin double staining).
[0038] Figure 16 The cell membrane of the HOBs+HOBs control group showed a double-layer structure, while the cell membrane of the BD:HOBs+HUVECs+HOBs pre-vascularization group showed a distinct sandwich shape.
[0039] Figure 17 The membrane sheets of the vascularization group and the control group were cultured for 3 and 7 days, and the expressions of BMP2 and VEGF-A proteins in the cell membrane sheets were detected by Western blot.
[0040] Figure 18 Figure 3: Immunofluorescence staining of the vascularized and control groups after 3-day culture. A: The thickness of the osteoblastic sheet in the vascularized group was significantly greater than that in the control group. BMP2 was expressed in most areas of both the control and vascularized groups. B: No VEGF-A expression was observed in the control group, while a large amount of VEGF-A was expressed in the pre-vascularized cell sheet group, with tubular positive distribution areas visible locally. DETAILED DESCRIPTION
[0041] The present invention will be further described below in conjunction with specific examples. It should be understood that these examples are intended to illustrate the present invention only and are not intended to limit the scope of the invention. Unless otherwise specified, the materials in the examples were prepared according to existing methods or directly purchased from the market. The experimental methods in the following examples, for which specific conditions are not specified, are generally performed according to conventional conditions, conditions described in laboratory manuals, or conditions recommended by the manufacturers.
[0042] Phosphate buffer (PBS): potassium dihydrogen phosphate (KH2PO4): 0.27 g, disodium hydrogen phosphate (Na2HPO4): 1.42 g, sodium chloride (NaCl): 8 g, potassium chloride (KCl) 0.2 g, add 800 mL of deionized water, stir thoroughly to dissolve, adjust the pH to 7.4, make up to 1 L, sterilize with high temperature and high pressure, and store at 4°C for later use.
[0043] Cryopreservative solution: Mix DMEM medium, serum, and dimethyl sulfoxide (DMSO) in a ratio of 6:3:1. Sterilize by filter filtration. Aliquot into 1 mL / cryotube and store at -40°C until use.
[0044] Osteogenic induction medium: Add 10-8 mol / L dexamethasone, 2.16 g / L sodium β-glycerophosphate, and 50 mg / L vitamin C to the above whole cell culture medium. Sterilize by filtration and store at 4°C in the dark.
[0045] 1% Alizarin Red Staining Solution: Weigh 1 g of Alizarin Red powder and add it to 100 mL of pre-prepared 0.1 M Tris-HCl. Mix thoroughly on a shaker in the dark, filter, and store in the dark at 4°C until use.
[0046] Materials and Methods
[0047] Specimens for this study were obtained from patients undergoing ultrasonic osteotome surgery at the Oral Surgery Clinic of the Ninth People's Hospital affiliated with Shanghai Jiao Tong University School of Medicine. Routine preoperative blood and urine tests, as well as infectious disease screening, revealed no systemic illness, infectious diseases, or past medical history. All bone tissue donors were between 20 and 40 years old. All donors provided written informed consent, and this study was approved by the hospital's ethics committee. Human umbilical vein vascular cells (HUVECs) were purchased from ATCC.
[0048] 1. Sample tissue block method cell culture
[0049] 1.1 Control group sample cell culture
[0050] Four healthy young patients (20-30 years old) were randomly selected as a fresh control group. Preoperatively, strict intraoral and extraoral disinfection and draping were performed. Under aseptic conditions, a subperiosteal flap was created on the buccal side of the impacted mandibular wisdom tooth. An ultrasonic bone scalpel (Piezotome2) was used to remove 15 mm × 10 mm cubes of bone. The surrounding periosteum, soft tissue, and bone marrow were scraped off, and bone fragments were cut into 2 mm × 2 mm pieces using rongeurs. The pieces were then placed in sterile phosphate-buffered saline (PBS). Under a clean bench, the pieces were repeatedly rinsed with sterile PBS containing double-antibody antibodies. Cells were transferred to six-well plates and seeded evenly. 2 mL of DMEM complete medium was added to each well. The plates were incubated at 37°C in a 5% CO2 incubator for 20 minutes. After the culture medium was aspirated, the plates were inverted for 2 hours. The plates were then placed upright and cultured for 5-7 days. Cell crawling was observed, photographed, and the medium was changed as needed. After the cells crawled out and formed colonies, the medium was changed every 3 days. Move the plate and change the medium as gently as possible to avoid dislodging or moving tissue fragments. After cells reach 90% confluence, aspirate the culture medium, wash twice with PBS, and digest with 0.25% trypsin containing EDTA for an appropriate time. Observe under a light microscope until cell processes begin to shrink. After aspirating the trypsin, terminate the digestion with serum-containing medium. Gently pipette the cells before passage, recording the passage date and number. For this experiment, the first P3 cells to emerge were designated the CTRL group (fresh bone-derived osteoblasts) for the following experiments.
[0051] 1.2 Sample recovery and cell culture in the experimental group
[0052] The cryopreservation records were queried and bone tissue samples that had been frozen for 1, 6, and 12 months were selected. At each time point, frozen bone tissue samples from 4 healthy young patients (20-30 years old) were randomly selected. After rapid rewarming in a 37°C constant temperature water bath, they were repeatedly rinsed with PBS to ensure that no cryopreservation protection solution remained. They were treated in the same way as the fresh control group and cultured into osteoblasts using the tissue block culture method. The medium was changed as appropriate in the first week. After 1 week, the medium was changed every 3 days until the cells reached 90% confluence and then subcultured. In this experiment, the first crawled-out P3 generation cells were selected and recorded as F1m group (bone-derived osteoblasts frozen for 1 month), F6m group (bone-derived osteoblasts frozen for 6 months), and F12m group (bone-derived osteoblasts frozen for 12 months) for the following experiments.
[0053] 2. Cell morphology observation
[0054] Four groups were assigned to this experiment: F1m (bone frozen for one month), F6m (bone frozen for six months), F12m (bone frozen for 12 months), and CTRL (fresh bone). Each group included bone tissue blocks from four donors. Under an inverted microscope, the time it took for osteoblasts to crawl out of the bone blocks and the number of colonies formed were recorded. Cell morphology was also compared between the groups at primary passage P0, passage P1, and during dense growth at P1.
[0055] 3. Comparison of cell proliferation ability detection
[0056] Cell Counting Kit-8 (CCK-8) contains WST-8: 2-(2-methoxy-4-nitrophenyl)-3-(4-nitrophenyl)-5-(2,4-disulfonatophenyl)-2H-tetrazolium monosodium salt. WST-8 is reduced by cellular dehydrogenases to a highly water-soluble yellow formazan dye in the presence of the electron carrier 1-methoxy-5-methylphenazinium methyl sulfate (1-Methoxy PMS). The amount of formazan generated is proportional to the number of viable cells. This property allows for simple and accurate analysis of cell proliferation and viability.
[0057] The specific steps are as follows:
[0058] 1) P3 osteoblasts in the logarithmic growth phase were collected from each group. When the cells reached approximately 90% confluence, they were digested with 0.25% trypsin. The cell suspension was then gently pipetted into a 50 mL centrifuge tube. Centrifuge at 1500 rpm for 5 minutes and discard the supernatant.
[0059] 2) After resuspending in DMEM, count the cells and add appropriate amount of DMEM to adjust the final concentration of the cell suspension to 2×10 4 pieces / mL.
[0060] 3) Each group contains 4 samples, with 3 replicates per sample. Inoculate 100 μL of cell suspension per well in a circle around the perimeter of four 96-well plates. Add an equal volume of PBS to each well and incubate in an incubator. Change the medium every other day. At 3, 5, 7, and 9 days after inoculation, randomly select one plate and change the medium with serum-free DMEM. Add 10 μL of CCK8 to each well and incubate in a dark incubator for 2 hours.
[0061] 4) Carefully remove any bubbles that may be present in each well, measure the absorbance (OD) at 450 nm using a microplate reader, and record the cell growth curve for each group.
[0062] 4. Osteogenesis-related gene expression
[0063] 1) P3 osteoblasts in the logarithmic growth phase were collected from each group. When the cells reached approximately 90% confluence, they were digested with 0.25% trypsin. The cell suspension was then gently pipetted into a 50 mL centrifuge tube. Centrifuge at 1500 rpm for 5 minutes and discard the supernatant.
[0064] 2) After resuspending in DMEM, count the cells and add appropriate amount of DMEM to adjust the final concentration of the cell suspension to 3×10 4 pieces / mL.
[0065] 3) Inoculate a six-well plate with 2 mL of cell suspension per well. Shake to ensure even cell growth. Let stand for a while before placing in an incubator for culture.
[0066] 4) The next day, the culture medium was replaced with osteogenic induction medium, and the medium was changed every other day. After one week, the cells were rinsed with PBS and 1 mL of Trizol was added to each well. After incubation at room temperature for 5-10 minutes, the cells were transferred to RNase-free EP tubes with appropriate pipetting. 0.4 mL of chloroform was added to each EP tube, and the cells were shaken thoroughly. The cells were allowed to stand for 5 minutes and centrifuged at 12,000 g for 15 minutes at 4°C. After separation, approximately 0.4 mL of the upper aqueous phase was aspirated and transferred to a new EP tube. 0.4 mL of isopropanol was added to each EP tube, and the cells were mixed thoroughly. The cells were allowed to stand for 10 minutes and centrifuged at 12,000 g for 5 minutes at 4°C to precipitate RNA. The supernatant was discarded, and the precipitate was washed repeatedly with DEPC solution containing 75% ethanol several times. The cells were centrifuged at 7,500 g for 5 minutes at 4°C. The supernatant was discarded, and the precipitate was dissolved in 10 μL of DEPC water.
[0067] 5) After measuring the RNA sample concentration and purity using a spectrophotometer, transfer 1000 ng of total RNA from each tube to a new EP tube. Add the following: 4 μL of 5× PrimerScript Buffer, 1 μL of PrimeScript RT Enzyme Mix, 1 μL of Oligo dT Primer, 1 μL of Random Hexamers, and make up to 20 μL with RNase-free dHO. Reverse transcribe to cDNA in a water bath at 37°C for 15 min, and terminate the reaction at 85°C for 5 s.
[0068] 6) Real-time qPCR was performed on the synthesized cDNA. The gene and primer designs are shown in Table 1.
[0069] Table 1 Primer sequences of osteogenesis-related genes
[0070]
[0071] Fluorescence real-time quantitative PCR was used to detect the expression levels of alkaline phosphatase (ALP), osteocalcin (OCN) and Runt-related transcription factor 2 (Runx2).
[0072] Reaction system: Premix Ex TaqⅡ10μL, PCRForward Primer1μL, PCR Reverse Primer1μL, cDNA 2μL, dH2O fill to 20μL.
[0073] Reaction program: pre-denaturation at 95°C for 30 s, 95°C for 5 s, and 60°C for 30 s, for 40 cycles.
[0074] The CTRL group was set as the control group, GAPDH was used as the internal reference, and the experiment was repeated 3 times. The relative expression levels of osteogenesis-related genes such as ALP, OCN, and Runx2 were calculated.
[0075] 5. Alkaline phosphatase (ALP) staining
[0076] 1) P3 osteoblasts in good growth condition were collected from the first migration of each group. After digestion with 0.25% trypsin, the cell suspension was gently pipetted and transferred to a 50 mL centrifuge tube. Centrifuge at 1500 rpm for 5 minutes and discard the supernatant.
[0077] 2) After resuspending in DMEM, count the cells and add appropriate amount of DMEM to adjust the final concentration of the cell suspension to 8×104 pieces / mL.
[0078] 3) Inoculate 12-well plates with 1 mL of cell suspension per well. Shake to ensure even cell growth. Let stand for a while before placing in an incubator for culture.
[0079] 4) Change the medium the next day, and then every other day. Perform ALP staining 7 days later.
[0080] 5) Aspirate the culture medium and fix the cells with 4% paraformaldehyde solution at 4°C for 30 minutes.
[0081] 6) Aspirate and discard the fixative solution, and rinse with PBS three times.
[0082] 7) Prepare ALP working solution according to the Bio-Tech ALP staining solution instructions and add to the well plate, submerging the bottom surface. Incubate at 37°C in the dark for 30 minutes, then rinse with water. Observe and photograph under an inverted microscope.
[0083] 6. Alizarin red (ARS) staining
[0084] 1) P3 osteoblasts in good growth condition were collected from the first migration of each group. After digestion with 0.25% trypsin, the cell suspension was gently pipetted and transferred to a 50 mL centrifuge tube. Centrifuge at 1500 rpm for 5 minutes and discard the supernatant.
[0085] 2) After resuspending in DMEM, count the cells and add appropriate amount of DMEM to adjust the final concentration of the cell suspension to 1×10 5 pieces / mL.
[0086] 3) Inoculate 12-well plates with 1 mL of cell suspension per well. Shake to ensure even cell growth. Let stand for a while before placing in an incubator for culture.
[0087] 4) The next day, the culture medium was changed to osteogenic medium, and then changed every other day (all with osteogenic medium). ARS staining was performed after 14 days.
[0088] 5) After aspirating the culture medium, fix the samples with 95% ethanol for 10 minutes, wash with PBS, and stain with 1% alizarin red solution for 15 minutes. Rinse gently three times with running water and observe under a microscope. Four randomly selected fields of view from each patient in each group were counted for alizarin red-positive calcium nodules under a 100x inverted microscope (mean ± SD, n = 4). One-way analysis of variance was performed, with P < 0.05 as the standard of significance.
[0089] 7. Senescence-associated β-galactosidase (SA-β-gal) staining
[0090] Cellular senescence is a complex physiological and pathological process involving multiple genes under cell cycle regulation. Senescent cells have distinct characteristics, including increased size and high expression of the enzyme β-galactosidase. This experiment was designed to investigate whether long-term active cryopreservation induces extensive senescence of osteoblasts within bone blocks.
[0091] Here are the steps:
[0092] 1) P3 osteoblasts in good growth condition were collected from the first migration of each group. After digestion with 0.25% trypsin, the cell suspension was gently pipetted and transferred to a 50 mL centrifuge tube. Centrifuge at 1500 rpm for 5 minutes and discard the supernatant.
[0093] 2) After resuspending in DMEM, count the cells and add appropriate amount of DMEM to adjust the final concentration of the cell suspension to 4×10 4 pieces / mL.
[0094] 3) Inoculate 12-well plates with 1 mL of cell suspension per well. Shake to ensure even cell growth. Let stand for a while before placing in an incubator for culture.
[0095] 4) After 24 hours of culture, discard the culture medium and rinse with PBS several times.
[0096] 5) Add the fixative solution in the kit and fix at room temperature for 10 minutes.
[0097] 6) Prepare staining solution in each well of a 12-well plate according to the following ingredients: 470 μL of staining buffer, 5 μL of staining supplement, and 25 μL of 20 mg / mL X-gal DMSO solution.
[0098] 7) Aspirate and discard the fixative solution and rinse twice with PBS.
[0099] 8) Add 0.5 mL of staining solution to each well, cover the plate, and incubate at 37°C overnight.
[0100] 9) Aspirate and discard the staining solution and store in glycerol.
[0101] 10) Observe and count the blue cells that stain positively under an inverted microscope at 100x magnification. Four fields of view were randomly selected from each patient sample in each group for SA-β-gal staining positive counts (Mean±SD, n=4). One-way analysis of variance was performed, with P<0.05 as the significance standard.
[0102] 8. Cell apoptosis detection
[0103] In the early stages of apoptosis, prior to the onset of apoptotic phenomena such as cell shrinkage, chromatin condensation, DNA fragmentation, and increased cell membrane permeability, membrane phosphatidylserine (PS) flips from the inside of the lipid membrane to the outside. Annexin V is a phospholipid-binding protein with a high affinity for phosphatidylserine. Therefore, it can bind to the cell membrane of cells in the early stages of apoptosis through exposed phosphatidylserine on the outside of the cell. Therefore, Annexin V can be used as a sensitive indicator for detecting early apoptosis. Propidium iodide (PI) is a nucleic acid dye that can only penetrate the cell membrane and stain the nucleus red in cells in the middle and late stages of apoptosis and dead cells due to increased cell membrane permeability. Therefore, using Annexin V in combination with PI can distinguish cells at different stages of apoptosis.
[0104] This experiment used the Annexin V-FITC / PI apoptosis double staining kit (BD Pharmingen, USA) and the steps were as follows:
[0105] 1) P3 osteoblasts in good growth condition were collected from the first migration of each group. After digestion with 0.25% trypsin, the cell suspension was gently pipetted and transferred to a 50 mL centrifuge tube. Centrifuge at 1500 rpm for 5 minutes and discard the supernatant.
[0106] 2) Resuspend the cells in 4°C pre-cooled PBS and centrifuge at 1500 rpm for 5 minutes to wash the cells.
[0107] 3) Dilute 10× Binding Buffer to 1× Binding Buffer with deionized water.
[0108] 4) Resuspend the cells in 300 μL of 1× Binding Buffer.
[0109] 5) Add 5 μL of Annexin V-FITC to each sample, mix well, and incubate in the dark for 15 minutes.
[0110] 6) Add 5 μL of PI and 200 μL of 1× Binding Buffer before testing on the instrument.
[0111] 9. Karyotype analysis
[0112] Human chromosomes have specific, relatively stable morphological structures (including chromosome number, length, centromere position, arm ratio, satellite size, etc.). Optical or electrochemical colorimetric devices allow for clear and intuitive visualization of the specific morphological structure of processed chromosomes. Comparison with the normal karyotype reveals the presence of chromosomal deletions, duplications, and inversions. Karyotyping, a human genetics test, involves pairing, numbering, and grouping the chromosomes of the human cells being tested according to their inherent chromosomal morphological characteristics, and then performing morphological analysis.
[0113] This experiment is used to analyze whether long-term active cryopreservation will cause irreversible damage to the chromosomal structure of osteoblasts within bone blocks, such as deletions, duplications, inversions, etc. The steps are as follows:
[0114] 1) P3 cells with good growth condition were taken from each group after the first crawling out. When they grew to 70% confluence, colchicine with a final concentration of 0.08 μg / mL and ethidium bromide (EB) with a final concentration of 5 μg / mL were added to the culture medium.
[0115] 2) After culturing for 3 hours, the cells were digested with 0.25% trypsin and centrifuged at 1000 rpm for 5 minutes, and the supernatant was discarded.
[0116] 3) Add a mixture of 0.5% potassium chloride and 0.5% sodium citrate and incubate in a 37°C water bath for 0.5 h. Add methanol and glacial acetic acid fixative for 30 min and centrifuge at 800 rpm for 5 min.
[0117] 4) Aspirate and discard most of the supernatant. Blow the remaining cell suspension evenly and drop it onto a glass slide soaked in pre-cooled glacial acetic acid. Allow to air dry.
[0118] 5) After the slides were bathed in trypsin at 37°C for 1 minute, they were rinsed and dried, and then stained with Giemsa for 10 minutes, and then washed and air-dried.
[0119] 6) Observe the number and dispersion of chromosome division phases under a microscope and take photos. A physician with relevant medical genetic testing qualifications will perform G-banding karyotype analysis and issue a report.
[0120] 10. Thawing frozen bone blocks and culturing cells in vitro
[0121] Bone tissue from patients aged 20 to 25 years was randomly selected from a tissue sample bank and cryopreserved for approximately 6 months. After thawing in a 37°C water bath, the tissue was placed in sterile PBs containing double-antibody and rinsed repeatedly. The tissue was transferred to a 6-well plate, and 2 mL of DMEM containing 10% fetal bovine serum and 200,000 units of penicillin and streptomycin was added to each well. Human osteoblasts (HOBs) were cultured and expanded in a 37°C incubator. After the cells crawled out to form colonies and grew to 90% confluence, they were subcultured. Cell viability was tested, and if there were no obvious abnormalities in osteogenic mineralization-related abilities, they were used as seed cells for future use.
[0122] 11. Dead cell staining to detect cell survival
[0123] HUVECs and HOBs cells were seeded in 24-well plates and grown to 80% confluence. They were then labeled with 50 μg / mL Fe₃O₄ MNPs for 0, 1, and 3 days. The cells were washed twice with PBS, and 0.5 mL of staining solution was added to each well. The cells were incubated at 37°C in the dark for 15–30 minutes. The cells were washed twice with PBS, covered with coverslips, and analyzed for cell viability using fluorescence microscopy.
[0124] 12. Prussian blue staining to detect the internalization of Fe3O4 MNPs
[0125] HUVECs and HOBs cells were grown to 80% confluence and labeled with Fe₃O₄ MNPs at concentrations of 0, 5, 25, and 50 μg / mL. After incubation for 1 hour, the cells were fixed with 4% paraformaldehyde for 30 minutes and rinsed twice with distilled water for 2 minutes each. The cells were then stained with Perlstain solution for 30 minutes, rinsed with distilled water for 5 minutes, counterstained with eosin solution, and rinsed with distilled water for 5 seconds. The cells were then dehydrated and transparentized, mounted with neutral gum, and observed under a microscope for endocytosis.
[0126] 13. Comparison of cell adhesion and membrane formation by phalloidin staining
[0127] Unlabeled cells served as a control group. HUVECs and HOBs were labeled with 50 μg / mL Fe₃O₄ MNPs for 30 minutes, 1 hour, and 2 hours. The cells were digested and resuspended, then transferred to a culture plate with a coverslip placed on the bottom of the wells. A circular N41 super magnet was placed underneath the wells. After a 4-hour incubation, non-adherent cells were repeatedly rinsed to remove the cells. The cells were fixed with 4% formaldehyde for 10 minutes, washed with PBS, and permeabilized with 0.5% Triton X-100 for 5 minutes. After another PBS wash, 200 μL of the prepared rhodamine-labeled phalloidin working solution was added to cover the cell slides and incubated at room temperature in the dark for 30 minutes. The coverslips were rinsed three times with PBS, and nuclei were stained with 200 μL of DAPI solution for 30 seconds. The cells were observed and images were acquired under a fluorescence microscope.
[0128] 15. Preparation of HOBs bilayer cell membrane
[0129] When the confluence of HOBs reached 100%, the medium was replaced with complete medium containing 50 μg / mL Fe3O4 MNPs and the cells were cultured for 1 hour. 4 / cm 2 The cells were seeded at the same density in a 12-well plate. An N41 super magnet was placed at the bottom of the plate to continuously attract the cells and prepare a monolayer of HOBs membranes. After a 4-hour interval, the cells were seeded again at the same density and the medium was changed once.
[0130] 16. Construction of pre-vascularized bilayer osteoblast membrane
[0131] The HUVECs labeled with 50 μg / mL Fe3O4 MNPs were seeded on the monolayer HOBs membrane prepared above at a density of 5×10 4 / cm 2 After 4 hours, 9×10 4 / cm 2 A single layer of osteoblasts was seeded at a density of 100 μg / mL to form the HOBs+HUVECs+HOBs prevascularization group. The culture medium was changed every day, and further testing was performed after 3 and 7 days of culture. A single layer of osteoblasts was used to construct a HOBs bilayer membrane sheet, which was designated the HOBs+HOBs control group. The culture medium was changed every day.
[0132] 17. Fluorescent labeling and tracing to detect the structural composition of cell membranes
[0133] After labeling HOBs with DiO and HUVECs with DiL, respectively, cell sheets were constructed using the aforementioned procedures: a control group of HOBs + HOBs and a prevascularized group of HOBs + HUVECs + HOBs. Both cell sheets were rapidly OCT-embedded. After trimming the sample blocks, 20-μm-thick frozen sections were cut from the longest longitudinal section. Images were acquired and observed under a fluorescence microscope.
[0134] 18. Western blot detection of BMP2 and VEGF-A protein expression levels
[0135] The protein expression levels of BMP2 and VEGF-A were compared between the HOBs + HOBs control group and the HOBs + HUVECs + HOBs prevascularization group. Samples were collected after 37 days of culture. Cells were lysed on ice for 30 minutes using lysis buffer, and the supernatant was collected by cold centrifugation. After protein quantification, 20 μg of each sample was separated by gel electrophoresis and transferred to a PVDF membrane. After blocking for 1 hour, the membranes were incubated with primary antibodies at 4°C overnight in the dark. Secondary antibodies were added and incubated at room temperature for 2 hours. The membranes were washed to remove residual secondary antibody, developed with chemiluminescent reagent, and the band images were scanned using a gel imaging analysis system.
[0136] 19. Immunofluorescence staining to detect BMP2 and VEGF-A protein levels
[0137] After 3 days of culture, harvest the cell membrane and prepare frozen sections using the same procedure as above. Fix with 4% formaldehyde for 10 minutes, clear with 0.5% Triton X-100 for 5 minutes, wash three times with PBS, and block with fetal bovine serum for 30 minutes. Add the primary antibody and incubate overnight at 4°C. Add the secondary antibody and incubate at room temperature for 2 hours. Stain the nuclei with DAPI to completely cover the cells. Then, apply anti-fluorescence quenching mounting medium in the dark and observe and acquire images under a fluorescence microscope.
[0138] Example 1: Collection of fresh human jaw tissue samples
[0139] Ultrasonic bone scalpel was used to remove the cortical bone at the outer oblique line of the mandible. During the operation, the incision was rinsed with 4℃ sterile saline to ensure that the bone would not necrotize and degenerate due to high temperature. Strict intraoral and extraoral disinfection was performed before the operation, and a drape was laid. During the operation, under sterile conditions, an incision was made on the buccal side of the mandibular impacted wisdom tooth to the subperiosteal flap (see Figure 1 b) and then use ultrasonic bone knife (Piezotome2) (see Figure 1 (a) Take a 15mm×10mm square bone block (see Figure 1 In (c), scrape the surrounding periosteum and other soft tissues and bone marrow, then use rongeurs to cut the bone into 2mm x 2mm pieces and place them in sterile phosphate-buffered saline (PBS). Rinse repeatedly with sterile PBS containing double-antibody under a UV-sterilized clean bench in the laboratory. Transfer and aliquot into sterile cryovials pre-chilled at 4°C, each containing 1mL of cryoprotectant solution: 10% DMSO, 30% FBS, and 60% DMEM medium. Label the cryovials with the freezing time and patient information, place them in a gradient cooling box, and cool them at a cooling rate of -1°C / min. After cooling to -80°C, scan the code using Avantech Sample Information Management Software, register them, and store them in a -80°C freezer for long-term storage.
[0140] Example 2
[0141] Bone tissue samples were selected and fixed with 2.5% glutaraldehyde for 48 hours, dehydrated with gradient alcohol, and the last step of dehydration with absolute alcohol was repeated twice. The samples were then dried with infrared ray. Vacuum was applied and gold was sprayed for 45 seconds. The samples were observed and photographed under an electron microscope. Obvious bone craters were observed on the surface of the bone blocks in each group ( Figure 2), osteoblasts crawled out from the edge of the tissue block, and after migrating and expanding, they became radial. 5-9 days after inoculation of fresh tissue blocks, and 7-14 days after thawing and inoculating frozen tissue blocks in each group, spindle-shaped or polygonal osteoblasts were seen crawling out and migrating around the tissue blocks. After another 7-10 days, the expanded cells became radial. After confluence to 70-80%, they were digested and passaged. After adhering to the wall, they were observed and photographed under an inverted phase contrast microscope at 100×. No obvious difference was seen in the morphology of the cells in each group. After 100% confluence, the cells in each group all became long spindle-shaped, roughly like fish scales ( Figure 3 Immunofluorescence staining of bone block-derived osteoblasts at different freezing times showed that freezing had no significant adverse effects on the adhesion function of bone block-derived osteoblasts ( Figure 4 There was no significant difference in cell viability among the groups ( Figure 5 )(P>0.05).
[0142] Example 3
[0143] ALP and Alizarin Red staining are specific staining indicators of osteogenic differentiation, representing enzyme secretion in the early stage of osteogenic differentiation and matrix secretion and calcification in the late stage of osteogenic differentiation, respectively. Positive results for both indicate that the cells are indeed osteoblasts. ALP staining of P3 generation frozen bone tissues at different times and osteoblasts from fresh bone showed purple-black granules or blocky precipitates in the cytoplasm, with a positive rate of over 90%. No significant differences were observed between the groups ( Figure 6 ); After one week of osteogenic induction culture, cells grew in overlapping layers. Alizarin red staining revealed scattered red nodules or plaques in all groups, which were uneven in size and particularly evident in the densely packed areas. No significant differences were observed between the groups under a light microscope. There was no significant difference in the number of calcium nodules between the groups (P>0.05). Figure 7 After culturing in osteogenic medium for one week, the expression levels of osteogenic-related genes such as Runx2, ALP, and OCN in frozen bone-derived osteoblasts were not significantly different from those in fresh bone-derived osteoblasts ( Figure 8 This indicates that different active cryopreservation times have no significant effect on the in vitro osteogenic capacity of osteoblasts in bone blocks.
[0144] Example 4
[0145] Hypothermia can effectively reduce the growth and metabolism of tissues and cells, slowing replicative aging and the accumulation of metabolic waste caused by cell growth and metabolism. However, the crystallization of intracellular water molecules during the cooling process and the recrystallization during the rewarming process are often considered to cause significant damage to cells.
[0146] Apoptosis, senescence, and chromosome structural variation tests were performed on the four groups of cells, and no significant differences or obvious abnormalities were found. It is worth mentioning that a small number of cells with positive β-galactosidase (SA-β-gal) staining were found in both fresh bone-derived and frozen bone-derived osteoblasts. No significant differences were observed under microscope observation, and there was no significant difference in the positive rate count (P>0.05) ( Figure 9 This indicates that cells in fresh bone will also undergo senescence as they expand, while no significant difference was observed between cells derived from bone blocks frozen at different time periods. Annexin V-FITC / PI double staining flow cytometry revealed that the apoptosis rate of cells in each group was low, and the dead cell rate was also relatively close. No significant difference was observed between the groups (P>0.05). Figure 10 Osteoblasts from bone blocks frozen for 1, 6, and 12 months, as well as osteoblasts from fresh bone, were collected and sent for karyotype analysis. More than 20 dividing cells were found in each group, and no abnormalities in chromosome number or structure were found at the G-banding level (400). Figure 11 These results demonstrate that -80°C is a viable storage temperature for active cryopreservation of mandibular tissue: mandibular tissue stored under these conditions maintains robust osteogenic activity for a year, and the expanded osteoblasts exhibit no significant differences in physiological function or in vitro osteogenic capacity compared to fresh bone-derived osteoblasts, with no correlation with cryopreservation duration. This demonstrates the feasibility of this method for long-term preservation of autologous human mandibular tissue and provides a theoretical basis for the low-cost clinical application of mandibular tissue banks.
[0147] Example 5
[0148] Bone tissue samples frozen for 6 months were selected, and cells were expanded and cultured after thawing. ALP and alizarin red staining were performed 0d, 4d, 7d, and 14d after osteogenic induction, and strong positive results were seen. It can be seen that there was no significant difference in ALP staining at 0d and 4d, and then gradually decreased. The results of alizarin red staining showed a positive correlation with time. This shows that the osteoblasts cultured after thawing bone blocks still maintained the osteogenic phenotype well after in vitro expansion culture ( Figure 12 ).
[0149] Example 6
[0150] The osteoblasts obtained from the above experiments and commercially purchased HUVECs were co-incubated with 50 μg / mL Fe3O4 MNPs (0-50 nm particle size) for 1 h. Prussian staining showed that the cells internalized Fe3O4 ( Figure 13 Live / dead cell double staining results showed that there was no difference in the survival of HOBs and HUVECs labeled with 50μg / mL Fe3O4 MNPs compared with the cell control group ( Figure 14). The effect of different labeling time of Fe3O4 MNPs on adhesion and membrane formation (DAPI + phalloidin double staining) HOBs and HUVECs were incubated with 50μg / mL Fe3O4MNPs for different time (0, 30min, 1h, 2h). Compared with the unlabeled control group and the 30min incubation group (more cells were round and wrinkled), the cytoskeleton was clearly stretched in the HOBs and HUVECs incubated for 1h and 2h after 50μg / mL labeling. Among them, the number of adherent cells in the 50μg / mL labeled HUVECs 1h and 2h groups was significantly more than that in the control group and 30min group ( Figure 15 ).
[0151] Example 7
[0152] After using DIO and DIL to label two types of cells, two cell membranes were constructed by magnetic attraction and then immunofluorescence staining was performed. A: The cell membrane of the HOBs+HOBs control group showed a double-layer structure; B-D: The cell membrane of the HOBs+HUVECs+HOBs pre-vascularized group showed a distinct sandwich structure, and vascular endothelial cells were partially seen to sprout through the osteoblast sheet ( Figure 16 ). The membrane sheets of the vascularization group and the control group were cultured for 3 and 7 days, and the expression of BMP2 and VEGF-A proteins in the cell membrane sheets was detected by Western blot. The protein expression level of VEGF-A in the HOBs+HUVECs+HOBs pre-vascularization group increased over time, and the VEGF-A protein expression levels at 3 days and 7 days were significantly higher than those in the control group; the BMP2 protein expression level at 7 days was significantly higher than that in the control group (P<0.01). However, the HOBs+HOBs control group almost did not express VEGF-A at 3 days, and expressed a small amount of VEGF-A at 7 days ( Figure 17 Immunofluorescence staining of the vascularized and control groups after 3 days of culture. A: The thickness of the osteoblastic membrane in the vascularized group was significantly greater than that in the control group. BMP2 was expressed in most areas of both the control and vascularized groups. B: No VEGF-A expression was observed in the control group, but a large amount of VEGF-A was expressed in the pre-vascularized cell sheet group, with tubular positive distribution areas visible locally ( Figure 18 ).
[0153] These results demonstrate that prevascularized osteoblast sheets can be successfully constructed in vitro by labeling with magnetic nanoparticles and then magnetically attracting cryopreserved bone-derived osteoblasts and vascular endothelial cells layer by layer. Compared with the control group, the expression levels of VEGF-A and BMP2 proteins in the prevascularized group were significantly increased, indicating that the control group, which also contained cryopreserved bone-derived osteoblast sheets, had a strong ability to promote bone formation, and prevascularization further enhanced this ability. In addition to their strong ability to promote bone formation, the prevascularized osteoblast sheets also exhibited excellent angiogenesis. Furthermore, their tube formation within the sheet provided better nutrition for the multiple layers of osteoblast sheets, and their sprout-like migration accelerated the vascularization process, thereby optimizing the effectiveness of bone tissue engineering repair.
[0154] In summary, this application uses an ultrasonic osteotome to harvest bones under the premise of pre-cooling in water at 4°C, and to build a storage library. It can accurately obtain relatively clean bone tissue with less trauma, and reduce the adverse effects on the bone block structure and internal cells. After resuscitation, the tissue block culture method can indeed culture osteoblasts, while also better maintaining the osteogenic phenotype and in vitro osteogenic ability of the osteoblasts inside the tissue block. After labeling with magnetic nanoparticles, frozen bone-derived osteoblasts and vascular endothelial cells are magnetically attracted layer by layer, thereby successfully constructing a pre-vascularized double-layer osteoblast membrane in vitro, which has good functions of promoting angiogenesis and promoting bone formation.
[0155] This specific embodiment is merely an explanation of the present application and is not a limitation of the present application. After reading this specification, those skilled in the art may make non-creative modifications to the present embodiment as needed, but as long as they are within the scope of the claims of the present application, they are protected by the patent law.
Claims
1. A method for preparing a pre-vascularized osteoblast membrane, characterized in that: The preparation method comprises the following steps: Step S1, freezing fresh jaw tissue; Step S2, resuscitating and culturing the frozen jaw tissue to obtain human osteoblasts (HOBs); Step S3, labeling the obtained osteoblasts (HOBs) and human umbilical vein endothelial cells (HUVECs) with magnetic nanoparticles; Step S4: After labeling, the labeled osteoblasts and human umbilical vein endothelial cells (HUVECs) are magnetically attracted layer by layer to prepare a pre-vascularized osteoblast membrane sheet.
2. The preparation method according to claim 1, characterized in that The freezing step is to place the fresh jaw tissue in a cryopreservation protection solution and gradually cool it to -80°C for long-term freezing. The cryopreservation protection solution is a culture medium containing 8-12% DMSO, 20-40% FBS, and 50-70% DMEM.
3. The preparation method according to claim 1, characterized in that The resuscitation step is to use a 35° C.-37° C. water bath for resuscitation.
4. The preparation method according to claim 1, characterized in that The magnetic nanoparticles in step S3 are Fe3O4 MNPs, and the concentration of the Fe3O4 MNPs is 45-55 μg / mL.
5. The preparation method according to claim 1, characterized in that Specifically, step S4 comprises continuously attracting labeled osteoblasts (HOBs) with a super magnet to obtain a single-layer HOBs membrane, inoculating labeled human umbilical vein endothelial cells (HUVECs) on the single-layer HOBs membrane, and then inoculating another layer of osteoblasts (HOBs) on the human umbilical vein endothelial cells (HUVECs) after an interval of 3-4 hours to obtain a pre-vascularized osteoblast membrane.
6. A pre-vascularized osteoblast membrane prepared by the preparation method according to any one of claims 1 to 5.
7. Use of the pre-vascularized osteoblast membrane sheet according to claim 6 in bone tissue regeneration engineering.
8. Use of osteoblasts derived from jaw tissue in the preparation of pre-vascularized osteoblast membranes, characterized in that: The osteoblasts are obtained from fresh jaw bone tissue by culturing after freezing and thawing.
9. The use according to claim 1, characterized in that The freezing is to place the fresh jaw tissue in a cryopreservation protection solution and then gradually cool it down to -80°C for long-term freezing. The cryopreservation protection solution is a culture medium containing 8-12% DMSO, 20-40% FBS, and 50-70% DMEM.
